Hologic is announcing its second new COVID-19 test – the Aptima SARS-CoV-2 assay, a molecular diagnostic – which runs on its market-leading high-throughput Panther System (machine) and has the potential to help double the testing capacity in the U.S. This is a game-changer in fighting the pandemic and will help people get back to work or quarantine themselves.

Read More at kadn.com